FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20114911000001105: Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1745601000001111 Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1745621000001116 Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Is a Sitagliptin 50mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Sitagliptin phosphate true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sitagliptin true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Sitagliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start